Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Animal models for SARS-CoV-2
Chung-Young Lee, Anice C. Lowen
Current Opinion in Virology (2021) Vol. 48, pp. 73-81
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

A roadmap to pulmonary delivery strategies for the treatment of infectious lung diseases
Siqin He, Jiajia Gui, Kun Xiong, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 103
Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model
Christopher Käufer, Cara Sophie Schreiber, Anna-Sophia Hartke, et al.
EBioMedicine (2022) Vol. 79, pp. 103999-103999
Open Access | Times Cited: 73
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications
Jonas Cerneckis, Hongxia Cai, Yanhong Shi
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 50
SARS-CoV-2 VOC type and biological sex affect molnupiravir efficacy in severe COVID-19 dwarf hamster model
Carolin M. Lieber, Robert M. Cox, Julien Sourimant, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Lactoferrin: Antimicrobial impacts, genomic guardian, therapeutic uses and clinical significance for humans and animals
Mohamed E. Abd El‐Hack, Sameh A. Abdelnour, Mahmoud Kamal, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114967-114967
Open Access | Times Cited: 22
Hamster organotypic modeling of SARS-CoV-2 lung and brainstem infection
Marion Ferren, Valérie Favède, Didier Décimo, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 53
SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
Michihito Sasaki, Shinsuke Toba, Yukari Itakura, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 43
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
Mariana F. Tioni, Robert Jordan, Angie Silva Pena, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 34
Timing of exposure is critical in a highly sensitive model of SARS-CoV-2 transmission
Ketaki Ganti, Lucas M. Ferreri, Chung-Young Lee, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 3, pp. e1010181-e1010181
Open Access | Times Cited: 27
Eight-amino-acid sequence at the N-terminus of SARS-CoV-2 nsp1 is involved in stabilizing viral genome replication
Shiori Ueno, Sodbayasgalan Amarbayasgalan, Yoshiro Sugiura, et al.
Virology (2024) Vol. 595, pp. 110068-110068
Closed Access | Times Cited: 6
Human Pluripotent Stem Cell–Derived Cardiomyocytes for COVID-19 Cardiovascular Complications: A Versatile In Vitro Model for Studying Acute and Chronic SARS-CoV-2 Infection
Carmen Lopez-Munoz, Noah Jackson Bowers, Silvia Marchianò
Current Treatment Options in Cardiovascular Medicine (2025) Vol. 27, Iss. 1
Closed Access
Review on the current status of Syrian hamsters as an animal model for COVID-19 transmission, pathogenesis, treatment and vaccine research
Biruh Mebratu Belay, Abebe Tesfaye Gessese, Mebrie Zemene Kinde, et al.
All Life (2025) Vol. 18, Iss. 1
Open Access
The pathological maelstrom of COVID-19 and cardiovascular disease
Mauro Giacca, Ajay M. Shah
Nature Cardiovascular Research (2022) Vol. 1, Iss. 3, pp. 200-210
Open Access | Times Cited: 24
Bovine lactoferrin inhibits SARS‐CoV‐2 and SARS‐CoV‐1 by targeting the RdRp complex and alleviates viral infection in the hamster model
Shiting He, Hongbo Qin, Lin Guan, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 21
Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2
Erika Cecon, Charlotte Izabelle, Sophie Le Poder, et al.
Journal of Pineal Research (2021) Vol. 72, Iss. 1
Open Access | Times Cited: 26
Quantitative proteomics of hamster lung tissues infected with SARS‐CoV‐2 reveal host factors having implication in the disease pathogenesis and severity
Voddu Suresh, Varshasnata Mohanty, Kiran Avula, et al.
The FASEB Journal (2021) Vol. 35, Iss. 7
Open Access | Times Cited: 25
Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection
Stuart Dowall, Francisco J. Salguero, Nathan R. Wiblin, et al.
Viruses (2021) Vol. 13, Iss. 11, pp. 2251-2251
Open Access | Times Cited: 24
Pathology and Immunity After SARS-CoV-2 Infection in Male Ferrets Is Affected by Age and Inoculation Route
Koen van de Ven, Harry van Dijken, Lisa Wijsman, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Mouse models in COVID-19 research: analyzing the adaptive immune response
Sabrina Clever, Asisa Volz
Medical Microbiology and Immunology (2022) Vol. 212, Iss. 2, pp. 165-183
Open Access | Times Cited: 16
Increased pathogenicity and aerosol transmission for one SARS-CoV-2 B.1.617.2 Delta variant over the wild-type strain in hamsters
Xinghai Zhang, Shaohong Chen, Zengguo Cao, et al.
Virologica Sinica (2022) Vol. 37, Iss. 6, pp. 796-803
Open Access | Times Cited: 15
Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
Peiyu Wang, Renwu Zhou, Rusen Zhou, et al.
Theranostics (2022) Vol. 12, Iss. 6, pp. 2811-2832
Open Access | Times Cited: 14
Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections
P. Reinke, Edmárcia Elisa de Souza, Sebastian Günther, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 8
A mouse xenograft long‐term replication yields a SARS‐CoV‐2 Delta mutant with increased lethality
Dongbum Kim, Minyoung Kim, Jin-Soo Kim, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 2
Closed Access | Times Cited: 2
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir
Wenfang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 4
Closed Access | Times Cited: 2
Dynamics of Trypanosoma cruzi infection in hamsters and novel association with progressive motor dysfunction
Harry C. Langston, Amanda Fortes Francisco, Ciaran Doidge, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 6, pp. e0012278-e0012278
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top